These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13040333)

  • 61. [Inefficacy of vitamin K antagonists in an human immunodeficiency virus seropositive patient taking nevirapine].
    Griffon C; Gaertner S; Mirea C; Welsch M; Stephan D
    Presse Med; 2009 Nov; 38(11):1696-8. PubMed ID: 19375272
    [No Abstract]   [Full Text] [Related]  

  • 62. [Anticoagulant therapy of thromboembolic diseases].
    CLOETENS W; TENZER C; MASCART P
    Acta Cardiol; 1952; 7(4):407-20. PubMed ID: 12975951
    [No Abstract]   [Full Text] [Related]  

  • 63. [Thromboembolic disease; anticoagulant therapy].
    ALESSANDRI H; DUCCI H; ROESCHMANN W; KATZ R; SPOERER A; TORIELLO L
    Rev Med Chil; 1953 Mar; 81(3):134-42. PubMed ID: 13075044
    [No Abstract]   [Full Text] [Related]  

  • 64. [Antivitamin K. Introduction].
    Larcan A
    Angeiologie; 1967; 19(5):33-5. PubMed ID: 5621970
    [No Abstract]   [Full Text] [Related]  

  • 65. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Anticoagulants].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1968 Jul; 23(4):217-28. PubMed ID: 4175980
    [No Abstract]   [Full Text] [Related]  

  • 67. Anticoagulants in venous thromboembolism. Prophylactic and therapeutic use.
    Hirsh J; Gallus AS
    Postgrad Med; 1974 Jan; 55(1):211-7. PubMed ID: 4588719
    [No Abstract]   [Full Text] [Related]  

  • 68. [Anticoagulant therapy with phenylindanedione; improved therapeutic plans; prolonged therapy].
    CARDI L; BIFFANI G
    Minerva Med; 1958 Jun; 49(45):2252-7. PubMed ID: 13565647
    [No Abstract]   [Full Text] [Related]  

  • 69. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Personal experience on indirect long-term anticoagulant therapy in ambulatory peripheral chronic arteriosclersis obliterans patients].
    Raso AM; Silvestrini P
    Angiologia; 1968; 20(6):301-16. PubMed ID: 5747170
    [No Abstract]   [Full Text] [Related]  

  • 71. [On the use of phenyl-2-indane-dione-1-3 in the prevention of thromboembolism in gynecologic surgery].
    Baly Y
    Lille Med; 1968 Feb; 13(2):Suppl:135-6. PubMed ID: 5745968
    [No Abstract]   [Full Text] [Related]  

  • 72. Anticoagulant therapy-practical management.
    Wright IS
    Am Heart J; 1969 Feb; 77(2):280-6. PubMed ID: 5762951
    [No Abstract]   [Full Text] [Related]  

  • 73. [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
    JURGENS R
    Schweiz Med Wochenschr; 1953 May; 83(20):471-5. PubMed ID: 13076081
    [No Abstract]   [Full Text] [Related]  

  • 74. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.
    SEVITT S; INNES D
    Lancet; 1964 Jan; 1(7325):124-9. PubMed ID: 14074476
    [No Abstract]   [Full Text] [Related]  

  • 75. [Thromboembolic complications, anticoagulant therapy and laboratory tests].
    PETTAVEL J
    Schweiz Med Wochenschr; 1957 Feb; 87(7):167-72. PubMed ID: 13421639
    [No Abstract]   [Full Text] [Related]  

  • 76. Prothrombin level during phenylindandione therapy; influence of the condition of the liver.
    TAWAST M; SIURALA M
    Ann Med Intern Fenn; 1955; 44(4):237-43. PubMed ID: 13327567
    [No Abstract]   [Full Text] [Related]  

  • 77. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The increase in postoperative thromboembolism and its treatment with anticoagulants].
    THOMASCHECK G
    Geburtshilfe Frauenheilkd; 1951 Dec; 11(12):1067-77. PubMed ID: 14926894
    [No Abstract]   [Full Text] [Related]  

  • 79. Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal.
    Taberner DA; Thomson JM; Poller L
    Br Med J; 1976 Jul; 2(6027):83-5. PubMed ID: 776348
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Long-term anticoagulant therapy with phenylindanedione].
    JORDE R
    Nord Med; 1955 Apr; 53(15):604-5. PubMed ID: 14384045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.